In contrast, administration of PAs into CCl4-induced rats’ hepatic fibrosis produced a significant reduction in DNA damage, as evidenced by a significant (P < 0.05) decrease in the values of these parameters, compared with the CCL4-treated rats. The gene discussed is CCL4; the disease is Hepatic fibrosis.